幸运快3
ABOUT US
Introduction
Chairman's Statement
Contact Us
R&D
R&D Platforms
R&D Capability
R&D Center
Scientific Activities
PRODUCTS
bFGF Series
other ophthalmic products
other surgical products
NEWS
company news
investee news
media focus
INVESTOR RELATIONS
Announcements & Shareholder Info
Corporate Info
Financial & ESG Reports
Contact Us
CAREERS
Talent Concept
Job Opportunities
簡
繁
EN
ABOUT US
Introduction
Chairman's Statement
Contact Us
R&D
R&D Platforms
R&D Capability
R&D Center
Scientific Activities
PRODUCTS
bFGF Series
other ophthalmic products
other surgical products
NEWS
company news
investee news
media focus
INVESTOR RELATIONS
Announcements & Shareholder Info
Corporate Info
Financial & ESG Reports
Contact Us
CAREERS
Talent Concept
Job Opportunities
簡
繁
EN
簡
繁
EN
INVESTEE NEWS
Mitotech brings novel approach to treating eye disorders
2021.05.03
Date
Title
2021-05-03
Mitotech brings novel approach to treating eye disorders
2019-07-22
AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer?, an Investigational Treatment for Alzheimer’s Disease
2019-05-14
MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency
2019-02-28
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies
Essex-Bio Group
BIOTECH
HEALTHTECH
Links
Contact us
Copyright ? 2020 Essex Bio-Technology Limited All Rights Reserved.
Disclaimer
|
Privacy Policy
This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.
ACCEPT
